Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 18/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4537059 | 0.84 | HSP90AA1 (0.35) | GRM5 | |
| SCHEMBL874610 | 0.82 | HSP90AA1 (0.35) | GRM5 | |
| SCHEMBL874316 | 0.82 | HSP90AA1 (0.35) | GRM5 | |
| SCHEMBL882995 | 0.80 | P2RX7 (0.40) | GRM5CYP1A2 | |
| SCHEMBL5020366 | 0.80 | CCR1 (0.41) | GRM5 | |
| SCHEMBL10273698 | 0.79 | HSP90AA1 (0.38) | GRM5CYP1A2 | |
| SCHEMBL882894 | 0.79 | HSP90AA1 (0.38) | GRM5 | |
| SCHEMBL882865 | 0.79 | HSP90AA1 (0.38) | GRM5 | |
| SCHEMBL5020358 | 0.78 | HSP90AA1 (0.36) | — | |
| SCHEMBL5020378 | 0.78 | GRM5 (0.37) | GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | GRM5 1821/4885CYP1A2 550/4885CYP3A4 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.